YY/T 1435-2016Tissue engineering medical device products—Standard guide for characterization of hydrogels (English PDF)
组织工程医疗器械产品水凝胶表征指南
This is a limited preview
Buy now to download the full PDF (18 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1435-2016 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
July 29, 2016
Implementation date
June 1, 2017
Scope
YY/T 1435-2016 is the English-translated version of 组织工程医疗器械产品水凝胶表征指南.
YY/T 1435-2016 is the Chinese pharmaceutical industry standard that guides the characterisation of the hydrogels used in tissue engineering medical device products: their biological properties, the kinetics of gel formation, their physical and chemical properties and their stability, and the way they release or deliver a substance.
It sets out the methods available for each of these and how the results are reported. Issued on 29 July 2016, it has applied since 1 June 2017.
Found what you need?
Document preview — YY/T 1435-2016
National Standard of the People's Republic of China
- Classification
- C 45
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Preface
- Introduction
- 1 Scope
- 2 normative reference document
- 3 Terms and definitions
- 4 important factors for hydrogel characterization
- 5 Biological characteristics
- 6 Dynamics
- 7 Physical and chemical properties and stability
- 8 material transfer
- 9 evaluation test selection
Foreword
This standard is drafted in accordance with the rules given in GB/T 1.1-2009.
Introduction
The hydrogel is a reticular polymer that swells in water and retains moisture in the polymer voids. Due to the existence of intermolecular crosslinking, hydration The glue can maintain a stable structure in the solid after swelling. The hydrogel material used in tissue engineering can be derived from natural polymers (e.g., algae Acid, chitosan and collagen), synthetic polymers [e.g., polyethylene glycol (PEG), polyvinyl alcohol (PVA)] or a mixture of both (e.g., PVA and Chitosan or gelatin). In clinical applications, hydrogels with or without the addition of a drug and/or a biological agent may be injected or implanted in the body.
Hydrogels are used primarily in tissue engineering as transport carriers for matrix substitutes, drugs and/or preparations, and environments that make up cell culture.
In the course of the application, the effect of the hydrogel depends on its ability to allow the dissolved gas, nutrients and bioactive substances to penetrate Ability to maintain cell growth and migration; ability to degrade; ability to release drugs and/or biological agents at a suitable rate;
1 Scope
This standard gives the biological properties of hydrogels used to characterize tissue engineering medical device products, forming kinetics, physical and chemical Sexuality and stability, as well as material delivery and other characteristics of the method guide.
2 Normative reference documents
The following documents are indispensable for the application of this document. For dated references, only the dated edition applies to this document. For undated references, the latest edition (including all modifications) applies to this document.
GB/T 16886.1 Biological evaluation of medical devices - Part 1. Evaluation and testing in risk management (GB/T 16886.1-2011, ISO 10993-1.:2009, IDT) A gel having a three-dimensional network structure formed by a polymer chain and retaining moisture in the intermolecular voids.
GB/T 16886.19 Biological evaluation of medical devices - Part 19. Physical chemistry, morphology and surface characterization of materials (GB/T 16886.19-2011, ISO /T S10993-19..2006, IDT)
Tissue engineering medical products - Part 5. Performance and testing of substrates and stents YY/T 0606.5 Tissue engineering medical products - Part 7. Chitosan Tissue engineering medical products - Part 8. Sodium alginate Tissue engineering medical products - Part 9. Sodium hyaluronate
YY/T 0771.1 Animal source medical devices - Part 1. Risk management applications (YY/T 0771.1-2009, ISO 22442-1. 2007, IDT) Pharmacopoeia of the People's Republic of China (2010 edition)
3 Terms and definitions
The following terms and definitions apply to this document.
3.1 Hydrogel
A gel having a three-dimensional network structure formed by a polymer chain and retaining moisture in the intermolecular voids.
3.2 Biocompatibility
The ability of a biomaterial to cause a proper response in a particular application. [ISO /T R15499..2012, definition 3.1]
Note. In the definition of the Scientific Committee of Materials Science, "biocompatibility" is the ability of a material to interact with a host during an application.
Material material is different from other high-tech materials, the most important features. Including hemocompatibility and histocompatibility. "Biocompatible material" is physiologically Environmental or biological, does not cause any adverse host reaction (material caused by the reaction of the body).
3.3 Exogenous factor
Contaminants present in raw materials and articles used in inoculants, cell matrices and/or manufactured products, including bacteria, fungi and mycoplasma.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 18 pages — is available in the English PDF.
Referenced standards
Normative references
- GB/T 16886.1Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
- GB/T 16886.19Biological evaluation of medical devices - Part 19: Physico-chemical, morphological and topographical characterization of materials
- YY/T 0771.1Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management
Similar standards
How to Download YY/T 1435-2016
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 16886.1-2022 — Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
GB/T 16886.19-2022 — Biological evaluation of medical devices - Part 19: Physico-chemical, morphological and topographical characterization of materials
YY/T 0771.1-2009 — Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management
Secure payment via Stripe
Payments accepted
YY/T 1435-2016
$205.00